>
Importing Poverty into America: Devolving Our Nation into Stupid
Grand Theft World Podcast 273 | Goys 'R U.S. with Guest Rob Dew
Anchorage was the Receipt: Europe is Paying the Price… and Knows it.
The Slow Epstein Earthquake: The Rupture Between the People and the Elites
Drone-launching underwater drone hitches a ride on ship and sub hulls
Humanoid Robots Get "Brains" As Dual-Use Fears Mount
SpaceX Authorized to Increase High Speed Internet Download Speeds 5X Through 2026
Space AI is the Key to the Technological Singularity
Velocitor X-1 eVTOL could be beating the traffic in just a year
Starlink smasher? China claims world's best high-powered microwave weapon
Wood scraps turn 'useless' desert sand into concrete
Let's Do a Detailed Review of Zorin -- Is This Good for Ex-Windows Users?
The World's First Sodium-Ion Battery EV Is A Winter Range Monster
China's CATL 5C Battery Breakthrough will Make Most Combustion Engine Vehicles OBSOLETE

MIT Technology Review reports that the first use of CRISPR in humans, to edit immune cells, has been proposed by scientists at the University of Pennsylvania. The National Institutes of Health's Recombinant DNA Advisory Committee will meet next week to review the the use of the technology.
The NIH writes in a blog post that the technique would be used to edit two genes in human T cells, which would target myeloma, melanoma, and sarcoma tumor cells.
This comes after an earlier proposal from Editas, a biotech company that plans to use CRISPR to treat eye disorders in 2017.